Global growth investor Warburg Pincus has acquired Pharma Intelligence, a provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from Informa, an international B2B markets knowledge services and business intelligence group.
Mubadala Investment Company, the Abu Dhabi based investment company, joins Warburg Pincus in the investment. The investors plan to extend the company’s position in the pharmaceutical data and analytics market, investing in the creation of innovative products for its customers. Informa will retain a 15 per cent stake in the company.
The acquisition includes Informa’s full portfolio of specialist brands which includes the Citeline suite of products, Trialtrove, Sitetrove, Pharmaprojects and Citeline branded products, as well as Biomedtracker, Clinerion, Datamonitor Healthcare, Pink Sheet, Scrip, Skipta, and TrialScope.
Read more: Private Equity Wire
